OR WAIT null SECS
January 22, 2021
GlaxoSmithKline (GSK) and Novartis have announced the launch of a collaboration to support scientific research into genetic diversity in Africa and the potential impact in response to drugs.
January 20, 2021
Through the acquisition, Thermo Fisher will have access to Mesa’s PCR-based rapid point-of-care testing platform for detecting infectious diseases.
The companies will develop up to three CD3-engaging T-cell redirecting bispecific antibody therapies using Merus' proprietary Biclonics platform.
January 19, 2021
ReFIBE sterile cleanroom wipes are sustainable polyester wipes made from recycled post-consumer plastic bottles.
The new US offices will give the company the ability to support its US-based customers on site while continuing to collaborate with its global team.
January 18, 2021
Henogen will be integrated into Thermo Fisher’s Pharma Services business within its Laboratory Products and Services segment.
The 40,000-ft.2 facility will feature eight cleanrooms with configurations for the production of cell and viral vector products.
January 15, 2021
The collaboration will focus on up to three types of lung and gastrointestinal cancers.
The acquisition significantly expands Precision Medicine Group’s cell and gene therapy expertise.
The fill line will work to manufacture high-value APIs for drug product manufacturing to meet the needs of the COVID-19 pandemic.